Loading...
Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction
Aim: A direct oral anti-coagulant, FXa inhibitor, has been applied to the clinical treatment of myocardial infarction (MI). Experimental studies in mice indicated that FXa inhibitors reduced atherosclerosis and prevented cardiac dysfunction after coronary ligation. These studies suggested that prote...
Na minha lista:
| Udgivet i: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Japan Atherosclerosis Society
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6800390/ https://ncbi.nlm.nih.gov/pubmed/30867376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.48405 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|